Skip to content

PRINTO (the Paediatric Rheumatology International Trials Organisation)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00415935
Enrollment
Unknown
Registered
2006-12-25
Start date
Unknown
Completion date
2006-12-31
Last updated
2006-12-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Juvenile Idiopathic Arthritis

Brief summary

A comparison of outcome in children with JIA who are in remission on MTX, when MTX is then stopped for either 6 or 12 months

Interventions

DRUGmethotrexate

Sponsors

Institute of Child Health
Lead SponsorOTHER

Study design

Observational model
DEFINED_POPULATION
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 16 Years
Healthy volunteers
No

Inclusion criteria

* Any child with JIA who has gone into remission using methotrexate

Countries

United Kingdom

Contacts

Primary ContactLucy Wedderburn, Dr
l.wedderburn@ich.ucl.ac.uk

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026